Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

01.01.2018

1 Am J Clin Oncol
1 Am J Surg
1 Ann Oncol
5 Anticancer Res
7 BMC Cancer
1 Breast Cancer
1 Breast Cancer (Dove Med Press)
2 Breast Cancer Res
12 Breast Cancer Res Treat
8 Breast J
4 Cancer
3 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
2 Cancer Res
1 Carcinogenesis
6 Clin Breast Cancer
2 Clin Cancer Res
4 Eur J Cancer
1 Eur J Surg Oncol
1 Int J Cancer
2 Int J Radiat Oncol Biol Phys
2 Lancet Oncol
1 N Engl J Med
3 Oncogene
1 Oncol Rep
12 PLoS One
1 Radiology
1 Radiother Oncol
4 Semin Oncol



    Am J Clin Oncol

  1. SINESHAW HM, Freedman RA, DeSantis CE, Jemal A, et al
    Treatment Patterns Among Women Diagnosed With Stage I-III Triple-negative Breast Cancer.
    Am J Clin Oncol. 2017 Dec 27. doi: 10.1097/COC.0000000000000418.
    >> Share


    Am J Surg

  2. QU LT, Peters S, Cobb AN, Godellas CV, et al
    Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment.
    Am J Surg. 2017 Nov 13. pii: S0002-9610(17)31018.
    >> Share


    Ann Oncol

  3. SWAIN SM, Ewer MS, Viale G, Delaloge S, et al
    Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study
    Ann Oncol. 2017 Dec 15. pii: 4748818. doi: 10.1093.
    >> Share


    Anticancer Res

  4. JARDEL P, Vignot S, Cutuli B, Creisson A, et al
    Should Adjuvant Radiation Therapy Be Systematically Proposed for Male Breast Cancer? A Systematic Review.
    Anticancer Res. 2018;38:23-31.
    >> Share

  5. CHAMARAUX-TRAN TN, Mathelin C, Aprahamian M, Joshi GP, et al
    Antitumor Effects of Lidocaine on Human Breast Cancer Cells: An In Vitro and In Vivo Experimental Trial.
    Anticancer Res. 2018;38:95-105.
    >> Share

  6. TAKASHIMA T, Kawajiri H, Nishimori T, Tei S, et al
    Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.
    Anticancer Res. 2018;38:379-383.
    >> Share

  7. KASHIWAGI S, Asano Y, Goto W, Takada K, et al
    Mesenchymal-epithelial Transition and Tumor Vascular Remodeling in Eribulin Chemotherapy for Breast Cancer.
    Anticancer Res. 2018;38:401-410.
    >> Share

  8. SVOBODOVA S, Kucera R, Fiala O, Marie K, et al
    CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer.
    Anticancer Res. 2018;38:465-469.
    >> Share


    BMC Cancer

  9. ASANO Y, Kashiwagi S, Goto W, Takada K, et al
    Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden.
    BMC Cancer. 2017;17:888.
    >> Share

  10. MERCOGLIANO MF, Inurrigarro G, De Martino M, Venturutti L, et al
    Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    BMC Cancer. 2017;17:895.
    >> Share

  11. LIU LN, Lin YC, Miaskowski C, Chen SC, et al
    Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status.
    BMC Cancer. 2017;17:863.
    >> Share

  12. KRISHNAN K, Baglietto L, Stone J, McLean C, et al
    Mammographic density and risk of breast cancer by tumor characteristics: a case-control study.
    BMC Cancer. 2017;17:859.
    >> Share

  13. LYNGE E, Bak M, von Euler-Chelpin M, Kroman N, et al
    Outcome of breast cancer screening in Denmark.
    BMC Cancer. 2017;17:897.
    >> Share

  14. HUANG LH, Chung HY, Su HM
    Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
    BMC Cancer. 2017;17:890.
    >> Share

  15. KUMARI K, Keshari S, Sengupta D, Sabat SC, et al
    Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.
    BMC Cancer. 2017;17:858.
    >> Share


    Breast Cancer

  16. ATTALLAH AM, El-Far M, Abdelrazek MA, Omran MM, et al
    HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer.
    Breast Cancer. 2017 Dec 28. pii: 10.1007/s12282-017-0829.
    >> Share


    Breast Cancer (Dove Med Press)

  17. EDESSA D, Sisay M
    Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2- metastatic breast cancer: a focus on ribociclib.
    Breast Cancer (Dove Med Press). 2017;9:567-579.
    >> Share


    Breast Cancer Res

  18. LI HY, Liang JL, Kuo YL, Lee HH, et al
    miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Breast Cancer Res. 2017;19:133.
    >> Share

  19. THOMSEN AML, Pedersen AB, Kristensen NR, Moller BK, et al
    Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients: a Danish population-based cohort study.
    Breast Cancer Res. 2017;19:135.
    >> Share


    Breast Cancer Res Treat

  20. PONDE N, Bradbury I, Lambertini M, Ewer M, et al
    Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06).
    Breast Cancer Res Treat. 2017 Dec 27. pii: 10.1007/s10549-017-4628.
    >> Share

  21. NAROD SA, Huzarski T, Gronwald J, Byrski T, et al
    Predictors of survival for breast cancer patients with a BRCA1 mutation.
    Breast Cancer Res Treat. 2017 Dec 15. pii: 10.1007/s10549-017-4605.
    >> Share

  22. KOSTEV K, Kalder M
    Long-term use of basal insulin and the risk of breast cancer.
    Breast Cancer Res Treat. 2017 Dec 26. pii: 10.1007/s10549-017-4631.
    >> Share

  23. ZIMMER AS, Zhu K, Steeg PS, Wu A, et al
    Analysis of breast cancer in young women in the Department of Defense (DOD) database.
    Breast Cancer Res Treat. 2017 Dec 15. pii: 10.1007/s10549-017-4615.
    >> Share

  24. TELLI ML, Hellyer J, Audeh W, Jensen KC, et al
    Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.
    Breast Cancer Res Treat. 2017 Dec 23. pii: 10.1007/s10549-017-4624.
    >> Share

  25. FAZZINO TL, Klemp J, Befort C
    Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors.
    Breast Cancer Res Treat. 2017 Dec 22. pii: 10.1007/s10549-017-4603.
    >> Share

  26. PICHILINGUE-FEBRES AF, Arias-Linares MA, Araujo-Castillo RV
    Comments on "Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors" by Parise CA and Caggiano V, Breast Cancer Res Treat, 2017.
    Breast Cancer Res Treat. 2017 Dec 21. pii: 10.1007/s10549-017-4620.
    >> Share

  27. UNDERWOOD EA, Rochon PA, Moineddin R, Lee PE, et al
    Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis.
    Breast Cancer Res Treat. 2017 Dec 20. pii: 10.1007/s10549-017-4627.
    >> Share

  28. KWAN ML, Yao S, Laurent CA, Roh JM, et al
    Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy.
    Breast Cancer Res Treat. 2017 Dec 16. pii: 10.1007/s10549-017-4626.
    >> Share

  29. DUGGAN C, Baumgartner RN, Baumgartner KB, Bernstein L, et al
    Genetic variation in TNFalpha, PPARgamma, and IRS-1 genes, and their association with breast-cancer survival in the HEAL cohort.
    Breast Cancer Res Treat. 2017 Dec 18. pii: 10.1007/s10549-017-4621.
    >> Share

  30. VAN SEIJEN M, Mooyaart AL, Mulder L, Hoogstraat M, et al
    Enrichment of high-grade tumors in breast cancer gene expression studies.
    Breast Cancer Res Treat. 2017 Dec 18. pii: 10.1007/s10549-017-4622.
    >> Share

  31. DU RUSQUEC P, Palpacuer C, Campion L, Patsouris A, et al
    Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Dec 15. pii: 10.1007/s10549-017-4623.
    >> Share


    Breast J

  32. PASRICHA S, Gupta G, Garg R, Sharma A, et al
    Impact of 2013 ASCO/CAP HER2 reporting guidelines in breast cancer: An assessment study from Indian oncology centre that primarily performs HER2 IHC testing with special emphasis on IHC equivocal category.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12981.
    >> Share

  33. KAIDAR-PERSON O, Deal AM, Anders CK, Ewend MG, et al
    The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.
    Breast J. 2017 Dec 18. doi: 10.1111/tbj.12919.
    >> Share

  34. HWANG E, Yap ML, Boxer MM, Chong S, et al
    Variations in breast cancer histology and treatment patterns between the major ethnic groups of South West Sydney.
    Breast J. 2017 Dec 19. doi: 10.1111/tbj.12973.
    >> Share

  35. GARG M, Prabhakar N, Singla V, Singh T, et al
    Breast cancer in a patient with neurofibromatosis type 1.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12987.
    >> Share

  36. MARTIN-ROMANO P, Baraibar I, Espinos J, Legaspi J, et al
    Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12975.
    >> Share

  37. MERCKEL LG, Verburg E, van der Velden BHM, Loo CE, et al
    Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12984.
    >> Share

  38. FONSECA V, Brito M
    Starting hormone therapy immediately after histological diagnosis of breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12995.
    >> Share

  39. DECOSTER L, Fontaine C, Vanacker L, Schallier D, et al
    Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer.
    Breast J. 2017 Dec 29. doi: 10.1111/tbj.12990.
    >> Share


    Cancer

  40. NUTTER EL, Weiss JE, Marotti JD, Barth RJ Jr, et al
    Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer.
    Cancer. 2017 Dec 20. doi: 10.1002/cncr.31202.
    >> Share

  41. ALTUNDAG K
    Diagnosis of patients with inflammatory breast cancer is a problematic issue.
    Cancer. 2017 Dec 19. doi: 10.1002/cncr.31189.
    >> Share

  42. BALTZELL KA, Shen HM, Krishnamurty S, Sison JD, et al
    Bovine leukemia virus linked to breast cancer but not coinfection with human papillomavirus: Case-control study of women in Texas.
    Cancer. 2017 Dec 20. doi: 10.1002/cncr.31169.
    >> Share

  43. ARUN BK, Gutierrez Barrera AM, Ueno NT
    Reply to Diagnosis of patients with inflammatory breast cancer is a problematic issue.
    Cancer. 2017 Dec 19. doi: 10.1002/cncr.31188.
    >> Share


    Cancer Epidemiol Biomarkers Prev

  44. WANG S, Zheng Y, Ogundiran TO, Ojengbede O, et al
    Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry.
    Cancer Epidemiol Biomarkers Prev. 2017 Dec 18. pii: 1055-9965.EPI-17-0755.
    >> Share

  45. REEVES KW, Okereke OI, Qian J, Tamimi RM, et al
    Depression, antidepressant use and breast cancer risk in pre- and postmenopausal women: a prospective cohort study.
    Cancer Epidemiol Biomarkers Prev. 2017 Dec 20. pii: 1055-9965.EPI-17-0707.
    >> Share

  46. MALONE KE, Korde LA, Doody DR, Hsu L, et al
    Bisphosphonate use and risk of recurrence, second primary breast cancer, and breast cancer mortality in a population-based cohort of breast cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2017 Dec 18. pii: 1055-9965.EPI-17-0556.
    >> Share


    Cancer Lett

  47. PLATONOV ME, Borovjagin AV, Kaverina N, Xiao T, et al
    KISS1 tumor suppressor restricts angiogenesis of breast cancer brain metastases and sensitizes them to oncolytic virotherapy in vitro.
    Cancer Lett. 2017 Dec 18. pii: S0304-3835(17)30796.
    >> Share


    Cancer Res

  48. MAEDA T, Hiraki M, Jin C, Rajabi H, et al
    MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer.
    Cancer Res. 2017 Dec 20. pii: 0008-5472.CAN-17-1636.
    >> Share

  49. EKAMBARAM P, Lee JL, Hubel NE, Hu D, et al
    The CARMA3-Bcl10-MALT1 Signalosome Drives NF-kappaB Activation and Promotes Aggressiveness in Angiotensin II Receptor-positive Breast Cancer.
    Cancer Res. 2017 Dec 19. pii: 0008-5472.CAN-17-1089.
    >> Share


    Carcinogenesis

  50. RINCON-FERNANDEZ D, Culler MD, Tsomaia N, Moreno-Bueno G, et al
    In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines.
    Carcinogenesis. 2017 Dec 19. pii: 4762760. doi: 10.1093.
    >> Share


    Clin Breast Cancer

  51. INOUE Y, Yamashita N, Kitao H, Tanaka K, et al
    Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30385.
    >> Share

  52. WADASADAWALA T, Lewis S, Parmar V, Budrukkar A, et al
    Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30383.
    >> Share

  53. FURRER D, Jacob S, Michaud A, Provencher L, et al
    Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30318.
    >> Share

  54. BASTIAANNET E, Charman J, Johannesen TB, Schrodi S, et al
    A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
    Clin Breast Cancer. 2017 Nov 29. pii: S1526-8209(17)30728.
    >> Share

  55. HAMELINCK VC, Bastiaannet E, Pieterse AH, van de Velde CJH, et al
    Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30409.
    >> Share

  56. FLEMING CA, McCarthy K, Ryan C, McCarthy A, et al
    Evaluation of Discordance in Primary Tumor and Lymph Node Response After Neoadjuvant Therapy in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30679.
    >> Share


    Clin Cancer Res

  57. ZHAO EY, Shen Y, Pleasance E, Kasaian K, et al
    Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer.
    Clin Cancer Res. 2017;23:7521-7530.
    >> Share

  58. MASTORAKI S, Strati A, Tzanikou E, Chimonidou M, et al
    ESR1 methylation: a liquid biopsy-based epigenetic assay for the follow up of patients with metastatic breast cancer receiving endocrine treatment.
    Clin Cancer Res. 2017 Dec 28. pii: 1078-0432.CCR-17-1181.
    >> Share


    Eur J Cancer

  59. DACKUS GMHE, Jozwiak K, Sonke GS, van der Wall E, et al
    Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study.
    Eur J Cancer. 2017;90:92-101.
    >> Share

  60. HOLM-RASMUSSEN EV, Jensen MB, Balslev E, Kroman N, et al
    The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
    Eur J Cancer. 2017;87:1-9.
    >> Share

  61. STRASSER-WEIPPL K, Sudan G, Ramjeesingh R, Shepherd LE, et al
    Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27.
    Eur J Cancer. 2017;90:19-25.
    >> Share

  62. ANDERSON JJ, Darwis NDM, Mackay DF, Celis-Morales CA, et al
    Red and processed meat consumption and breast cancer: UK Biobank cohort study and meta-analysis.
    Eur J Cancer. 2017;90:73-82.
    >> Share


    Eur J Surg Oncol

  63. ONG JSL, Teh J, Saunders C, Bourke AG, et al
    Patient satisfaction with Radioguided Occult Lesion Localisation using iodine-125 seeds ('ROLLIS') versus conventional hookwire localisation.
    Eur J Surg Oncol. 2017;43:2261-2269.
    >> Share


    Int J Cancer

  64. ANDERSON C, Engel SM, Anders CK, Nichols HB, et al
    Live birth outcomes after adolescent and young adult breast cancer.
    Int J Cancer. 2017 Dec 21. doi: 10.1002/ijc.31227.
    >> Share


    Int J Radiat Oncol Biol Phys

  65. OHRI N, Moshier E, Ho A, Green S, et al
    Postmastectomy Radiation in Breast Cancer Patients With Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends.
    Int J Radiat Oncol Biol Phys. 2017;99:549-559.
    >> Share

  66. HORTON JK, Jagsi R, Woodward WA, Ho A, et al
    Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;100:23-37.
    >> Share


    Lancet Oncol

  67. BURKI TK
    Improved progression-free survival in metastatic breast cancer.
    Lancet Oncol. 2017 Dec 21. pii: S1470-2045(17)30952.
    >> Share

  68. NELSON R
    San Antonio Breast Cancer Symposium 2017.
    Lancet Oncol. 2017 Dec 14. pii: S1470-2045(17)30930.
    >> Share


    N Engl J Med

  69. TURNER NC
    Signatures of DNA-Repair Deficiencies in Breast Cancer.
    N Engl J Med. 2017;377:2490-2492.
    >> Share


    Oncogene

  70. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Dec 18. pii: onc2017407. doi: 10.1038/onc.2017.
    >> Share

  71. HOWLEY BV, Link LA, Grelet S, El-Sabban M, et al
    A CREB3-regulated ER-Golgi trafficking signature promotes metastatic progression in breast cancer.
    Oncogene. 2017 Dec 18. pii: 10.1038/s41388-017-0023.
    >> Share

  72. HAN B, Zhou B, Qu Y, Gao B, et al
    FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.
    Oncogene. 2017 Dec 18. pii: 10.1038/s41388-017-0021.
    >> Share


    Oncol Rep

  73. SHENG C, Qiu J, He Z, Wang H, et al
    Suppression of Kpnbeta1 expression inhibits human breast cancer cell proliferation by abrogating nuclear transport of Her2.
    Oncol Rep. 2018;39:554-564.
    >> Share


    PLoS One

  74. SOBRAL-LEITE M, Lips EH, Vieira-Monteiro HA, Giacomin LC, et al
    Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.
    PLoS One. 2017;12:e0189750.
    >> Share

  75. DABI Y, Darrigues L, Pons K, Mabille M, et al
    Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms.
    PLoS One. 2017;12:e0189385.
    >> Share

  76. LIU CY, Lau KY, Hsu CC, Chen JL, et al
    Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
    PLoS One. 2017;12:e0189007.
    >> Share

  77. RUMNEY RMH, Coffelt SB, Neale TA, Dhayade S, et al
    PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development.
    PLoS One. 2017;12:e0188591.
    >> Share

  78. FIOCCHETTI M, Cipolletti M, Marino M
    Compensatory role of Neuroglobin in nervous and non-nervous cancer cells in response to the nutrient deprivation.
    PLoS One. 2017;12:e0189179.
    >> Share

  79. FATIMA I, El-Ayachi I, Taotao L, Lillo MA, et al
    The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2017;12:e0189864.
    >> Share

  80. CARNESECCHI J, Cerutti C, Vanacker JM, Forcet C, et al
    ERRalpha protein is stabilized by LSD1 in a demethylation-independent manner.
    PLoS One. 2017;12:e0188871.
    >> Share

  81. SYED BM, Morgan D, Setty T, Green AR, et al
    Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2017;12:e0188528.
    >> Share

  82. BENNANI-BAITI B, Dietzel M, Baltzer PA
    MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    PLoS One. 2017;12:e0188679.
    >> Share

  83. DENIZ S, Kurt B, Oguzoncul AF, Nazlican E, et al
    Knowledge, attitudes and behaviours of women regarding breast and cervical cancer in Malatya, Turkey.
    PLoS One. 2017;12:e0188571.
    >> Share

  84. ORTIZ AB, Garcia D, Vicente Y, Palka M, et al
    Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    PLoS One. 2017;12:e0188068.
    >> Share

  85. CATTANEO ER, Prieto ED, Garcia-Fabiani MB, Montanaro MA, et al
    Glycerol-3-phosphate acyltransferase 2 expression modulates cell roughness and membrane permeability: An atomic force microscopy study.
    PLoS One. 2017;12:e0189031.
    >> Share


    Radiology

  86. BAHL M, Gaffney S, McCarthy AM, Lowry KP, et al
    Breast Cancer Characteristics Associated with 2D Digital Mammography versus Digital Breast Tomosynthesis for Screening-detected and Interval Cancers.
    Radiology. 2017 Dec 22:171148. doi: 10.1148/radiol.2017171148.
    >> Share


    Radiother Oncol

  87. AZNAR MC, Duane FK, Darby SC, Wang Z, et al
    Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015.
    Radiother Oncol. 2017 Dec 12. pii: S0167-8140(17)32742.
    >> Share


    Semin Oncol

  88. SOURBIER C, Neckers L
    Uncoupling tumor-stroma interactions in breast cancer patients.
    Semin Oncol. 2017;44:235-236.
    >> Share

  89. MONTI D, Sotgia F, Whitaker-Menezes D, Tuluc M, et al
    Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer.
    Semin Oncol. 2017;44:226-232.
    >> Share

  90. CAPOLUONGO E, Ellison G, Lopez-Guerrero JA, Penault-Llorca F, et al
    Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.
    Semin Oncol. 2017;44:187-197.
    >> Share

  91. BAS Y, Hassan HA, Adiguzel C, Bulur O, et al
    The distribution of cancer cases in Somalia.
    Semin Oncol. 2017;44:178-186.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016